• Home
  • 股东权益

Sichenzia Ross Ference LLP代表Aegis Capital Corp.作为独家账簿管理人完成对Avinger,Inc.普通股的1,440万美元要约收购

avinger logo

Press Release – New York, NY – February 2, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten offering of 10,000,000 shares of the common stock of Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $1.44 per share. The gross proceeds of the offering were approximately $14.4 million, prior to deducting underwriting discounts and commissions and estimated offering expenses.

新闻稿–纽约,纽约– 2021年2月2日– Sichenzia Ross Ference LLP今天宣布代表Aegis Capital Corp.作为独家账簿管理人,承销Avinger,Inc.(NASDAQ:AVGR)1000万股普通股,这是一家商业阶段的医疗设备公司,以每股1.44美元的价格销售第一个也是唯一的基于血管内图像引导的导管系统,用于诊断和治疗外周动脉疾病(PAD)。扣除承销折扣和佣金以及估计的发行费用之前,发行的总收益约为1,440万美元。


Sichenzia Ross Ference LLP团队由合伙人Gregory Sichenzia,Darrin M. Ocasio和Jay Yamamoto以及其合伙人Matthew Siracusa领导。

Sichenzia Ross Ference LLP
Latest posts by Sichenzia Ross Ference LLP (see all)